Researchers developed a single-cell sequencing method that simultaneously measures cancer-linked DNA mutations and gene ...

Cancer is commonly known as a disorder that is difficult to recover and therapy that places a heavy burden on patients such as surgical treatment and anticancer drug treatment is applied, but research ...

The ability of a mutation to cause cancer depends on how fast it forces cells to divide, according to a new study led by researchers at the Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health ...

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms ...

A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing key genes, EZH2 drives chaotic cell divisions and fuels metastasis.

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...